loadpatents
name:-0.010602951049805
name:-0.016049861907959
name:-0.00050687789916992
Levine; Myron M. Patent Filings

Levine; Myron M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Levine; Myron M..The latest application filed is for "enhanced shigella-enterotoxigenic e. coli multi-valent vaccine".

Company Profile
0.14.9
  • Levine; Myron M. - Columbia MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Enhanced Shigella-Enterotoxigenic E. coli multi-valent vaccine
App 20210121553 - Barry; Eileen M. ;   et al.
2021-04-29
Compositions and methods for producing bacterial conjugate vaccines
Grant 10,716,839 - Tennants , et al.
2020-07-21
Compositions and Methods for Producing Bacterial Conjugate Vaccines
App 20180099038 - Tennants; Sharon M. ;   et al.
2018-04-12
Broad spectrum vaccine against non-typhoidal Salmonella
Grant 9,050,283 - Levine , et al. June 9, 2
2015-06-09
Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease
Grant 9,011,871 - Levine , et al. April 21, 2
2015-04-21
Attenuated Salmonella enterica serovar paratyphi a and uses thereof
Grant 8,475,810 - Vindurampulle , et al. July 2, 2
2013-07-02
Broad Spectrum Vaccine Against Typhoidal and Non-typhoidal Salmonella Disease
App 20130129776 - Levine; Myron M. ;   et al.
2013-05-23
Attenuated Salmonella enterica serovar paratyphi A and uses thereof
Grant 8,137,930 - Vindurampulle , et al. March 20, 2
2012-03-20
Attenuated Salmonella Enterica Serovar Paratyphi A And Uses Thereof
App 20120029173 - Vindurampulle; Christofer ;   et al.
2012-02-02
Broad Spectrum Vaccine Against Non-Typhoidal Salmonella
App 20110274714 - Levine; Myron M. ;   et al.
2011-11-10
Vaccines and Immunomodulatory Therapies for Tularemia
App 20110020399 - Santiago; Araceli ;   et al.
2011-01-27
Attenuated Salmonella Enterica Serovar Paratyphi a and Uses Thereof
App 20080233094 - Vindurampulle; Christofer ;   et al.
2008-09-25
Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
Grant 7,399,474 - Altboum , et al. July 15, 2
2008-07-15
Isolation and characterization of the csa operon (ETEC-CS4 Pili) and methods of using same
App 20050136070 - Altboum, Zeev ;   et al.
2005-06-23
Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
Grant 6,902,736 - Altboum , et al. June 7, 2
2005-06-07
Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
App 20020176868 - Altboum, Zeev ;   et al.
2002-11-28
Attenuated mutants of salmonella which constitutively express the Vi antigen
Grant 6,190,669 - Noriega , et al. February 20, 2
2001-02-20
Antibodies having binding specificity to ShET2, an enterotoxin of Shigella flexneri 2A
Grant 5,686,580 - Fasano , et al. November 11, 1
1997-11-11
Vibrio cholerae strain CVD103Hg.sup.r, method of making same, and vaccines derived therefrom
Grant 5,628,994 - Kaper , et al. May 13, 1
1997-05-13
Vibrio cholerae strain CVD103Hg.sup.r, method of making same, and vaccines derived therefrom
Grant 5,399,494 - Kaper , et al. * March 21, 1
1995-03-21
Method of isolating restriction fragment deletions in vibrio cholerae and products thereof
Grant 4,935,364 - Kaper , et al. June 19, 1
1990-06-19
Company Registrations
SEC0001306927Levine Myron M

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed